Errrrone on here fighting over really nothing at the end of the day (I think it was the NDQ listing that started it).
Who effin cares when that happens... The real goose for your gander is the OSA results and they are coming soon. Like real soon. If they good, we $1, if they bad, NDQ won't mean diddly squat. Do you think US investors will be lining up out the door if the first in human trial IHL does is a failure? No, simples as that. It'll chuck a cloud of doubt over the whole development pipeline IHL has (look at what happened to BOT) and we will be begging for scraps like CPH...
For clarity sake, my bets are on the former given the historical data / trials, interim results being used to generate patent claims & a Phase IIB off the back of it. However, NDQ listing is just a smoke screen for the real progression event that's coming our ways.
Stop all this sh*t and lets get the threads back on track.
IHL Price at posting:
33.0¢ Sentiment: Buy Disclosure: Held
